High pressure induces scrapie-like prion protein misfolding and amyloid fibril formation

Biochemistry

Volumn 43, Issue 22, 2004, Pages 7162-7170

  Torrent, Joan ^a   Alvarez Martinez, Maria Teresa ^b   Harricane, Marie Cécile ^c   Heitz, Frédéric ^c   Liautard, Jean Pierre ^b   Balny, Claude ^a   Lange, Reinhard ^a  

^a UNIV MONTPELLIER   (France)

^b INSERM   (France)

^c Centre National de la Recherche Scientifique   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AGGLOMERATION; BIOCHEMISTRY; CONFORMATIONS; DISEASES; PATHOLOGY; STRUCTURE (COMPOSITION);

PRE-AMYLOID STRUCTURES; PRION PROTEIN (PRP) MISFOLDING;

PROTEINS;

AMYLOID; CONGO RED; PRION PROTEIN; RECOMBINANT PROTEIN;

ARTICLE; ESCHERICHIA COLI; FLUORESCENCE SPECTROSCOPY; FOURIER TRANSFORMATION; INFRARED SPECTROSCOPY; LIGHT SCATTERING; NEUROLOGIC DISEASE; NONHUMAN; PRION DISEASE; PRIORITY JOURNAL; PROTEIN FOLDING; PROTEIN STRUCTURE; SCRAPIE; TRANSMISSION ELECTRON MICROSCOPY;

AMYLOID; ANILINO NAPHTHALENESULFONATES; ANIMALS; CONGO RED; CRICETINAE; ENDOPEPTIDASE K; FLUORESCENT DYES; PRESSURE; PRION DISEASES; PRIONS; PROTEIN CONFORMATION; PROTEIN FOLDING; RECOMBINANT PROTEINS; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

CRICETINAE; ESCHERICHIA COLI;

EID: 2642521246     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi049939d     Document Type: Article

References (56)

1. Prusiner, S. B. (1997) Prion diseases and the BSE crisis, Science 278, 245-251.
2. Carrell, R. W., and Lomas, D. A. (1997) Conformational disease, Lancet 350, 134-138.
3. Prusiner, S. B., Scott, M. R., DeArmond, S. J., and Cohen, F. E. (1998) Prion protein biology, Cell 93, 337-348.
4. Oesch, B., Westaway, D., Walchli, M., McKinley, M. P., Kent, S. B., Aebersold, R., Barry, R. A., Tempst, P., Teplow, D. B., Hood, L. E., et al. (1985) A cellular gene encodes scrapie PrP 27-30 protein, Cell 40, 735-746.
5. Stahl, N., Borchelt, D. R., Hsiao, K., and Prusiner, S. B. (1987) Scrapie prion protein contains a phosphatidylinositol glycolipid, Cell 51, 229-240.
6. Cohen, F. E., and Prusiner, S. B. (1998) Pathologic conformations of prion proteins, Annu. Rev. Biochem. 67, 793-819.
7. Glockshuber, R. (2001) Folding dynamics and energetics of recombinant prion proteins, Adv. Protein Chem. 57, 83-105.
8. Jonas, J. (2002) High-resolution nuclear magnetic resonance studies of proteins, Biochim. Biophys. Acta 1595, 145-159.
9. Silva, J. L., Foguel, D., and Royer, C. A. (2001) Pressure provides new insights into protein folding, dynamics and structure, Trends Biochem. Sci. 26, 612-618.
10. Randolph, T. W., Seefeldt, M., and Carpenter, J. F. (2002) High hydrostatic pressure as a tool to study protein aggregation and amyloidosis, Biochim. Biophys. Acta 1595, 224-234.
11. Torrent, J., Alvarez-Martinez, M. T., Heitz, F., Liautard, J. P., Balny, C., and Lange, R. (2003) Alternative prion structural changes revealed by high pressure, Biochemistry 42, 1318-1325.
12. Alvarez-Martinez, M. T., Torrent, J., Lange, R., Verdier, J. M., Balny, C., and Liautard, J. P. (2003) Optimized overproduction, purification, characterization and high-pressure sensitivity of the prion protein in the native (PrP(C)-like) or amyloid (PrP(Sc)-like) conformation, Biochim. Biophys. Acta 1645, 228-240.
13. Kitamura, Y., and Itoh, T. (1987) Reaction volume of protonic ionization for buffering agents - Prediction of pressure-dependence of pH and pOH, J. Solution Chem. 16, 715-725.
14. Mehlhom, I., Groth, D., Stockel, J., Moffat, B., Reilly, D., Yansura, D., Willett, W. S., Baldwin, M., Fletterick, R., Cohen, F. E., Vandlen, R., Henner, D., and Prusiner, S. B. (1996) High-level expression and characterization of a purified 142-residue polypeptide of the prion protein, Biochemistry 35, 5528-5537.
15. Zhang, H., Stockel, J., Mehlhorn, I., Groth, D., Baldwin, M. A., Prusiner, S. B., James, T. L., and Cohen, F. E. (1997) Physical studies of conformational plasticity in a recombinant prion protein, Biochemistry 36, 3543-3553.
16. Byler, D. M., and Susi, H. (1986) Examination of the secondary structure of proteins by deconvolved FTIR spectra, Biopolymers 25, 469-487.
17. Goormaghtigh, E., Cabiaux, V., and Ruysschaert, J. M. (1990) Secondary structure and dosage of soluble and membrane proteins by attenuated total reflection Fourier transform infrared spectroscopy on hydrated films, Eur. J. Biochem. 193, 409-420.
18. Smeller, L., Goossens, K., and Heremans, K. (1995) How to minimize certain artifacts in Fourier self-deconvolution, Appl. Spectrosc. 10, 1538-1542.
19. James, T. L., Liu, H., Ulyanov, N. B., Farr-Jones, S., Zhang, H., Donne, D. G., Kaneko, K., Groth, D., Mehlhorn, I., Prusiner, S. B., and Cohen, F. E. (1997) Solution structure of a 142-residue recombinant prion protein corresponding to the infectious fragment of the scrapie isoform, Proc. Natl. Acad. Sci. U.S.A. 94, 10086-10091.
20. Liu, H., Farr-Jones, S., Ulyanov, N. B., Llinas, M., Marqusee, S., Groth, D., Cohen, F. E., Prusiner, S. B., and James, T. L. (1999) Solution structure of Syrian hamster prion protein rPrP(90-231), Biochemistry 38, 5362-5377.
21. Baskakov, I. V., Legname, G., Baldwin, M. A., Prusiner, S. B., and Cohen, F. E. (2002) Pathway complexity of prion protein assembly into amyloid, J. Biol. Chem. 277, 21140-21148.
22. Kim, Y. S., Randolph, T. W., Stevens, F. J., and Carpenter, J. F. (2002) Kinetics and energetics of assembly, nucleation, and growth of aggregates and fibrils for an amyloidogenic protein. Insights into transition states from pressure, temperature, and co-solute studies, J. Biol. Chem. 277, 27240-27246.
23. Stockel, J., and Hartl, F. U. (2001) Chaperonin-mediated de novo generation of prion protein aggregates, J. Mol. Biol. 313, 861-872.
24. Cordeiro, Y., Machado, F., Juliano, L., Juliano, M. A., Brentani, R. R., Foguel, D., and Silva, J. L. (2001) DNA converts cellular prion protein into the beta-sheet conformation and inhibits prion peptide aggregation, J. Biol. Chem. 276, 49400-49409.
25. Zou, W. Q., Zheng, J., Gray, D. M., Gambetti, P., and Chen, S. G. (2004) Antibody to DNA detects scrapie but not normal prion protein, Proc. Natl. Acad. Sci. U.S.A. 101, 1380-1385.
26. Caughey, B., and Kocisko, D. A. (2003) Prion diseases: a nucleic-acid accomplice? Nature 425, 673-674.
27. Deleault, N. R., Lucassen, R. W., and Supattapone, S. (2003) RNA molecules stimulate prion protein conversion, Nature 425, 717-720.
28. Weiss, S., Proske, D., Neumann, M., Groschup, M. H., Kretzschmar, H. A., Famulok, M., and Winnacker, E. L. (1997) RNA aptamers specifically interact with the prion protein PrP, J. Virol. 71, 8790-8797.
29. Warner, R. G., Hundt, C., Weiss, S., and Turnbull, J. E. (2002) Identification of the heparan sulfate binding sites in the cellular prion protein, J. Biol. Chem. 277, 18421-18430.
30. Kuwata, K., Li, H., Yamada, H., Legname, G., Prusiner, S. B., Akasaka, K., and James, T. L. (2002) Locally disordered conformer of the hamster prion protein: a crucial intermediate to PrPSc? Biochemistry 41, 12277-12283.
31. Martins, S. M., Chapeaurouge, A., and Ferreira, S. T. (2003) Folding intermediates of the prion protein stabilized by hydrostatic pressure and low temperature, J. Biol. Chem. 278, 50449-50455.
32. Engelhard, M., and Evans, P. A. (1995) Kinetics of interaction of partially folded proteins with a hydrophobic dye: evidence that molten globule character is maximal in early folding intermediates, Protein Sci. 4, 1553-1562.
33. LeVine, H., 3rd. (1993) Thioflavine T interaction with synthetic Alzheimer's disease beta-amyloid peptides: detection of amyloid aggregation in solution, Protein Sci. 2, 404-410.
34. Carrotta, R., Bauer, R., Waninge, R., and Rischel, C. (2001) Conformational characterization of oligomeric intermediates and aggregates in beta-lactoglobulin heat aggregation, Protein Sci. 10, 1312-1318.
35. Dima, R. I., and Thirumalai, D. (2002) Exploring the propensities of helices in PrP(C) to form beta sheet using NMR structures and sequence alignments, Biophys. J. 83, 1268-1280.
36. Jamin, N., Coic, Y. M., Landon, C., Ovtracht, L., Baleux, F., Neumann, J. M., and Sanson, A. (2002) Most of the structural elements of the globular domain of murine prion protein form fibrils with predominant beta-sheet structure, FEBS Lett. 529, 256-260.
37. Sokolowski, F., Modler, A. J., Masuch, R., Zirwer, D., Baier, M., Lutsch, G., Moss, D. A., Gast, K., and Naumann, D. (2003) Formation of critical oligomers is a key event during conformational transition of recombinant syrian hamster prion protein, J. Biol. Chem. 278, 40481-40492.
38. Baskakov, I. V., Legname, G., Prusiner, S. B., and Cohen, F. E. (2001) Folding of prion protein to its native alpha-helical conformation is under kinetic control, J. Biol. Chem. 276, 19687-19690.
39. Collinge, J. (2001) Prion diseases of humans and animals: their causes and molecular basis, Annu. Rev. Neurosci. 24, 519-550.
40. Lashuel, H. A., Hartley, D., Petre, B. M., Walz, T., and Lansbury, P. T., Jr. (2002) Neurodegenerative disease: amyloid pores from pathogenic mutations, Nature 418, 291.
41. Kayed, R., Head, E., Thompson, J. L., McIntire, T. M., Milton, S. C., Cotman, C. W., and Glabe, C. G. (2003) Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis, Science 300, 486-489.
42. Balny, C., Masson, P., and Heremans, K. (2002) High-pressure effects on biological macromolecules: from structural changes to alteration of cellular processes, Biochim. Biophys. Acta. 1595, 3-10.
43. Foguel, D., Suarez, M. C., Ferrao-Gonzales, A. D., Porto, T. C., Palmieri, L., Einsiedler, C. M., Andrade, L. R., Lashuel, H. A., Lansbury, P. T., Kelly, J. W., and Silva, J. L. (2003) Dissociation of amyloid fibrils of {alpha}-synuclein and transthyretin by pressure reveals their reversible nature and the formation of water-excluded cavities, Proc. Natl. Acad. Sci. U.S.A. 100, 9831-9836.
44. Ferrao-Gonzales, A. D., Palmieri, L., Valory, M., Silva, J. L., Lashuel, H., Kelly, J. W., and Foguel, D. (2003) Hydration and packing are crucial to amyloidogenesis as revealed by pressure studies on transthyretin variants that either protect or worsen amyloid disease, J. Mol. Biol. 328, 963-974.
45. Zhou, J. M., Zhu, L., Balny, C., and Perrett, S. (2001) Pressure denaturation of the yeast prion protein Ure2, Biochem. Biophys. Res. Commun. 287, 147-152.
46. Perrett, S., and Zhou, J. M. (2002) Expanding the pressure technique: insights into protein folding from combined use of pressure and chemical denaturants, Biochim. Biophys. Acta 1595, 210-223.
47. Mozhaev, V. V., Heremans, K., Frank, J., Masson, P., and Balny, C. (1996) High-pressure effects on protein structure and function, Proteins 24, 81-91.
48. Frye, K. J., and Royer, C. A. (1998) Probing the contribution of internal cavities to the volume change of protein unfolding under pressure, Protein Sci. 7, 2217-2222.
49. Royer, C. A. (2002) Revisiting volume changes in pressure-induced protein unfolding, Biochim. Biophys. Acta 1595, 201-209.
50. Hummer, G., Garde, S., Garcia, A. E., Paulaitis, M. E., and Pratt, L. R. (1998) The pressure dependence of hydrophobic interactions is consistent with the observed pressure denaturation of proteins, Proc. Natl. Acad. Sci. U.S.A. 95, 1552-1555.
51. Gabizon, R., and Taraboulos, A. (1997) Of mice and (mad) cows-transgenic mice help to understand prions, Trends Genet. 13, 264-269.
52. Raymond, G. J., Hope, J., Kocisko, D. A., Priola, S. A., Raymond, L. D., Bossers, A., Ironside, J., Will, R. G., Chen, S. G., Petersen, R. B., Gambetti, P., Rubenstein, R., Smits, M. A., Lansbury, P. T., Jr., and Caughey, B. (1997) Molecular assessment of the potential transmissibilities of BSE and scrapie to humans, Nature 388, 285-288.
53. Scott, M., Groth, D., Foster, D., Torchia, M., Yang, S. L., DeArmond, S. J., and Prusiner, S. B. (1993) Propagation of prions with artificial properties in transgenic mice expressing chimeric PrP genes, Cell 73, 979-988.
54. Telling, G. C., Scott, M., Mastrianni, J., Gabizon, R., Torchia, M., Cohen, F. E., DeArmond, S. J., and Prusiner, S. B. (1995) Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein, Cell 83, 79-90.
55. Van Eldik, R., Asano, T., and Le Noble, W. J. (1989) Activation and reaction volume in solution 2, Chem. Rev. 89, 549-688.
56. Gsponer, J., Haberthur, U., and Caflisch, A. (2003) The role of side-chain interactions in the early steps of aggregation: Molecular dynamics simulations of an amyloid-forming peptide from the yeast prion Sup35, Proc. Natl. Acad. Sci. U.S.A. 100, 5154-5159.